Loading...

NUVB NUVATION BIO INC Company Mergers 8-K Filing

NVTN

NVB

NUVATION BIO INC

(NUVB)

2026 8-K

Annual Meeting Results

Financial Results Announced

Financial Results Announced

New License Agreement

Drug Development Update

Positive Study Results

Financial Results Released

Earnings Releases

Pre-Market Approval

Financial Statements

Supply Agreement

Financial Results

Supply Agreement

Loan Agreements

Financial Results

CFO Appointment

Annual Meeting Results

Financial Results Announcement

Financial Results Announcement

Acquisition Completed

Merger Agreement

Financial Results Announcement

Appointment of Director

Resignation of Director

Financial Results Announcement

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Earnings Reports

Petition for Resolution of ...

External Links:

On January 11, 2026, Nuvation Bio Inc. signed a License Agreement with Eisai Co., Ltd. granting them exclusive rights to develop a drug in several countries for €50 million upfront and potential additional payments up to €145 million.

AI Assistant

NUVATION BIO INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.